Clinical trial
A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent…
NCT00045708 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00045708 |
|---|---|
| Title | A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-Grade Gliomas |
| Official title | A Phase I/II Trial of BMS-247550 for Treatment of Patients With Recurrent High-grade Gliomas |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Adult Anaplastic Astrocytoma, Adult Giant Cell Glioblastoma, Adult Gliosarcoma, Recurrent Adult Brain Tumor |
| Intervention type | Drug, Other |
| Interventions | ixabepilone, pharmacological study, Anticonvulsant |
| Enrollment | 57 |
| Start date | Oct 1, 2002 |
| Primary completion | May 1, 2010 |
| Completion | May 1, 2010 |
| First posted | Jan 27, 2003 |
| Last update posted | Oct 18, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: